Indoor Tanning Legislation 2016
…for 12 months. Source: AIM at Melanoma and StateNet. Note: List may not be comprehensive but is representative of the state…
Indoor Tanning Legislation 2016
…for 12 months. Source: AIM at Melanoma and StateNet. Note: List may not be comprehensive but is representative of the state…
Indoor Tanning Legislation 2015
…for 12 months. Source: AIM at Melanoma and StateNet. Note: List may not be comprehensive but is representative of the state…
Indoor Tanning Legislation 2014
…for 12 months. Source: AIM at Melanoma and StateNet. Note: List may not be comprehensive but is representative of the state…
Share your Gratitude
…prefer not to respond Stage of Melanoma Stage IStage IIStage IIIStage IVN/APrefer not to respond What are you Grateful For?*…
Indoor Tanning Legislation 2021
…Source: AIM at Melanoma and StateNet. Note: List may not be comprehensive but is representative of the state laws that…
Costs of Participating in Clinical Trials
…Routine care for melanoma would be needed regardless of whether someone is in a clinical trial or not. For example, visits to…
Early Clinical Trial Shows Drug Activity to Work in Patients with Acral and Mucosal Melanoma
Results of a Phase 1/2 clinical trial showed promising data for patients with advanced acral and mucosal melanoma. The results…
,
Opdivo® (nivolumab) Approved as Adjuvant Treatment for Eligible Patients with Completely Resected Stage IIB or Stage IIC Melanoma
…in Patients with Resected Early-Stage Melanoma. Dermatol Ther (Heidelb). 2020;10(5):985-999. doi:10.1007/s13555-020-00404-9 What Is Melanoma Skin Cancer? American Cancer Society. https://www.cancer.org/cancer/melanoma-skin-cancer/about/what-is-melanoma.html.…
,
,
FDA Grants Toripalimab Fast Track Designation for Mucosal Melanoma
…drug designation is an important milestone for the nemvaleukin alfa program and underscores nemvaleukin’s potential clinical utility in mucosal melanoma,…
,
,
Alkermes Announces FDA Orphan Drug Designation for Nemvaleukin Alfa for Treatment of Mucosal Melanoma
…nemvaleukin alfa program and underscores nemvaleukin’s potential clinical utility in mucosal melanoma, a particularly aggressive form of melanoma for which…
,
,
Recent Posts
Apr. 02, 2026
Uveal Melanoma Webinar: Part II — Navigating Treatment in the Metastatic Setting
Mar. 26, 2026
Wade Watson, Stage III Melanoma Survivor
Mar. 03, 2026
Cancer is More Than a Diagnosis: Mind, Meaning, and Healing
Feb. 19, 2026
Merlin CP-GEP Becomes the First and Only Gene Expression Profile Test Recommended by NCCN®
Feb. 05, 2026